Langeveld C H, van Waas M P, Stoof J C, Sutanto W, de Kloet E R, Wolbers J G, Heimans J J
Department of Neurology, Faculty of Medicine, Free University, Amsterdam, The Netherlands.
J Neurosci Res. 1992 Mar;31(3):524-31. doi: 10.1002/jnr.490310316.
Dexamethasone is frequently used in the therapy of brain tumor patients. We investigated the effect of dexamethasone on the proliferation of three short-term and four established human glioma cell lines in vitro, using a microculture tetrazolium assay to determine growth rates. In one short-term culture and in one established cell line dexamethasone consistently stimulated the proliferation in a concentration-dependent way. The proliferation was maximally enhanced at a concentration of approximately 0.1 microM. In these two cell lines a relatively high level of glucocorticoid receptors was present, whereas low levels of glucocorticoid receptors were found in the other cell lines. In addition, we demonstrated that the stimulatory effects of dexamethasone on the proliferation of the glioma cell lines can be antagonized by the antiglucocorticoid RU38486. The results demonstrate unequivocally that the glucocorticoid receptor plays a role in the growth stimulating effect of dexamethasone.
地塞米松常用于脑肿瘤患者的治疗。我们使用微量培养四氮唑法测定生长速率,研究了地塞米松对三种短期培养和四种已建立的人胶质瘤细胞系体外增殖的影响。在一种短期培养物和一种已建立的细胞系中,地塞米松始终以浓度依赖的方式刺激增殖。在浓度约为0.1微摩尔时增殖得到最大增强。在这两种细胞系中存在相对高水平的糖皮质激素受体,而在其他细胞系中发现糖皮质激素受体水平较低。此外,我们证明地塞米松对胶质瘤细胞系增殖的刺激作用可被抗糖皮质激素RU38486拮抗。结果明确表明糖皮质激素受体在地塞米松的生长刺激作用中发挥作用。